Savers Value Village (SVV) Form 144 Reveals Recent Insider Sales
Rhea-AI Filing Summary
Form 144 notice for Savers Value Village, Inc. (SVV) reports a proposed sale of 2,300 common shares through Fidelity Brokerage Services with an aggregate market value of $29,900.50. The filing lists the total number of outstanding shares as 155,555,984 and an approximate sale date of 09/05/2025. The securities are shown as acquired on 09/05/2025 pursuant to an option granted on 06/12/2019, and payment is indicated as cash. The form also discloses multiple sales by Richard Medway over the prior three months totaling 120,119 shares for approximately $1,360,877.75. The filer attests no undisclosed material adverse information and the notice is submitted as a live filing.
Positive
- Clear compliance with Rule 144 disclosure requirements including broker, share counts, and aggregate value
- Disclosure of acquisition details (option grant date 06/12/2019) provides provenance for the securities
- Detailed prior sales history for the past three months enhances transparency
Negative
- Significant insider selling in the past three months (120,119 shares) which may concern some investors
- No 10b5-1 plan date provided in the remarks, so it is unclear whether sales were pre-planned
Insights
TL;DR: A routine Section 144 sale filing showing a small scheduled sale and substantial prior insider disposals over the past three months.
The Form 144 documents a proposed sale of 2,300 common shares valued at $29,900.50 against 155,555,984 shares outstanding, which is immaterial in size relative to the total share count. However, the disclosed prior insider transactions by Richard Medway total 120,119 shares and roughly $1.36 million in proceeds over the past three months, indicating meaningful insider liquidity during the period. From a market-impact perspective, the single proposed sale is small, but the recent concentrated selling activity may be relevant for investors monitoring insider selling trends. The filing provides acquisition provenance (option grant dated 06/12/2019) and indicates cash payment.
TL;DR: Form 144 appears compliant and transparent but reflects notable insider disposition in recent months.
The notice includes required disclosures: broker name and address, exact share counts, aggregate value, acquisition date and nature (option grant), and a brokered sale date. The signer affirms no undisclosed material adverse information, satisfying the attestation element. The series of prior sales by the same individual is documented in detail, which supports regulatory compliance and provides transparency on insider behavior. There is no indication in the filing of any trading plan adoption date or other 10b5-1 instruction in the remarks section.